Stocks Health care PEPG
NASDAQ · Health carePepGen Inc. (PEPG)
It posted a net loss of $71.9M. In fiscal 2025 capital spending exceeded operating cash flow by $81.9M. At June 30, 2026 it held $22.8M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
What PepGen Inc. does
PepGen Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PEPG.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$89.7M | -$2.12 | -$81.9M |
| 2024 | n/a | -$90M | -$2.85 | -$82.9M |
| 2023 | n/a | -$78.6M | -$3.30 | -$71.6M |
| 2022 | n/a | -$69.1M | -$4.42 | -$63M |
| 2022 | n/a | -$27.3M | -$30.27 | -$23.1M |
Latest SEC filings
What PepGen Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 6, 2026
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026
- June 22, 2026
- May 21, 2026
- May 18, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
- May 15, 2026Passive stake changed SCHEDULE 13G/A
- May 12, 2026
- May 12, 2026Quarterly report 10-Q · period to March 31, 2026
- April 28, 2026
Questions about PEPG
What does PepGen Inc. do?
PepGen Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PEPG.
Is PepGen Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $71.9M.
When did PepGen Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026.
Similar companies
Follow PEPG
Get an email when PepGen Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow PEPG: get an email when it filesWhere the numbers come from
Financial figures are the values PepGen Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.